It does seem to me that the letter to shareholders appears to be cobbled together at the last minute, and full of excuses rather than introduce any new information or offer guidance.

The assertion that the Olympics was a high profile event for Alda was absolutely contrary to my personal experience. I had visited a number of pavillions and sites and rarely saw an Alda dispenser. I saw more one step ads and Purell dispensers than anything T36 related. I'm sorry but the "We're busy"excuse just doesn't fly with me. How much time would it take to do a short update during something as high profile as the Olympics?

Blaming the sliding share price on Europe's woes is ludicrous. You want to really know why the share price was plummeting? Try lack of investor relation support, and transparency of what management is up to.

Maintaining core distributors/retailers relationship? I have not seen T36 at the local T&T, IGA, and it's sitting in the bargain bin at the local Shoppers Drug Mart. Even at $2.50 for a big bottle, it's not moving fast. If I'm actively looking for their product and can't find it, what chance do they have from catching the eye of the casual shopper. Promises of lucrative sales and how well received the product is means nothing if it doesn't translate to a fatter bottom line.

As a long time shareholder, I am growing impatient with TO and Alda. My hope is that the therapeutic uses and the FDA approval gets fast tracked, and a reasonable takeover bid comes sooner than later. On the next pop, I plan on divesting some money out. I'm sorry if I sound overly negative but I am just frustrated at the lack of initiative by management in capitalizing on events. With H1N1, Olympics, and FDA news, the only reason that we're languishing can only be attributed to management. Let the finger pointing begin.